Back to News
Market Impact: 0.2
Pacific Biosciences of California, Inc. Announces CFO Transition and Reports Q3 2026 Financial Results
Source: Nasdaq
Management & Governance
Pacific Biosciences said CFO, principal financial officer and principal accounting officer Jim Gibson stepped down effective November 3, 2026, and transitioned to a non-executive advisory role. The article excerpt does not specify a successor or the reason for the change.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
PACB-0.20
More News
- Cloudflare’s appeal won’t fix what’s broken in Delaware’s Chancery Court
- Paraguay President Pena resigns in wake of bank collapse
- Mattel cuts annual forecasts as new CEO takes charge
- Wendy's rejects takeover proposal from Nelson Peltz’s Trian
- How the Democratic party flipped the House and Senate, in 12 charts
- Wendy’s Rejects Takeover Bid From Peltz's Trian